Combination Therapy Offers CONFIDENCE to CKD+T2D Patients ...Middle East

Medscape - News
Combination Therapy Offers CONFIDENCE to CKD+T2D Patients
Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if backed by outcomes, herald a “new age” of care, suggests a landmark trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Combination Therapy Offers CONFIDENCE to CKD+T2D Patients )

Apple Storegoogle play

Also on site :

Most viewed in News